• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Beta Bionics, Inc. - Common Stock (NQ:BBNX)

    18.87 -0.11 (-0.58%)
    Delayed Quote Updated: 4:00 PM EDT, Oct 1, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,137,520
    Open 19.35
    Bid (Size) 18.05 (900)
    Ask (Size) 19.20 (100)
    Prev. Close 18.98
    Today's Range 18.39 - 19.44
    52wk Range 8.800 - 32.71
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Kaplan Fox Reminds Beta Bionics, Inc. (NASDAQ: BBNX) Investors With Significant Losses to Seek a Leadership Role Before Deadline on November 3, 2026
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    Important Notice to Long-Term Shareholders of Beta Bionics, Inc. (NASDAQ: BBNX); Better Home & Finance Holding Company (NASDAQ: BETR); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Office is Investigating Claims on Your
    From Grabar Law Office
    Via GlobeNewswire

    Performance

    YTD
    -35.5%
    -35.5%
    1 Month
    -5.4%
    -5.4%
    3 Month
    +13.0%
    +13.0%
    6 Month
    +88.5%
    +88.5%
    1 Year
    -5.0%
    -5.0%

    More News

    Read More
    News headline image
    Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc. - BBNX
    From SkyMedia, LLC
    Via GlobeNewswire
    News headline image
    Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors With Significant Losses to Contact the Firm Before November 3, 2026
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    Kaplan Fox Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors to a Securities Class Action Lawsuit – Contact the Firm Before Deadline on November 3, 2026 for Leadership Role
    From Kaplan Fox & Kilsheimer, LLP
    Via GlobeNewswire
    News headline image
    BETA BIONICS, INC. (BBNX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Beta Bionics, Inc. Investors of Upcoming Deadline
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    News headline image
    Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
    From Kahn Swick & Foti, LLC
    Via GlobeNewswire
    News headline image
    Kaplan Fox Alerts Investors to an Upcoming Deadline of November 3, 2026 in the Beta Bionics, Inc. (NASDAQ: BBNX) Securities Class Action
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines – BBNX
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit
    From Schall, Brown & Schwartz LLP
    Via GlobeNewswire
    News headline image
    Kaplan Fox Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Seek Leadership in a Securities Fraud Lawsuit by November 3, 2026
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    Beta Bionics to Announce Third Quarter 2026 Financial Results on October 27, 2026
    From Beta Bionics, Inc.
    Via GlobeNewswire
    News headline image
    Kaplan Fox & Kilsheimer LLP Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors to the Lead Plaintiff Deadline on November 3, 2026
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    Kaplan Fox Reminds Beta Bionics, Inc. (NASDAQ: BBNX) Investors of a Securities Class Action Deadline on November 3, 2026
    From Kaplan Fox & Kilsheimer, LLP
    Via GlobeNewswire
    News headline image
    Kaplan Fox & Kilsheimer LLP Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before November 3, 2026
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors with Losses to Contact the Firm Before November 3, 2026
    From Kaplan Fox & Kilsheimer, LLP
    Via GlobeNewswire
    News headline image
    BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit
    From Schall, Brown & Schwartz LLP
    Via GlobeNewswire
    News headline image
    Kaplan Fox & Kilsheimer LLP Reminds Investors of a Securities Class Action Against Beta Bionics, Inc. (NASDAQ: BBNX) and Lead Plaintiff Deadline on November 3, 2026
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc. - BBNX
    From SkyMedia, LLC
    Via GlobeNewswire
    News headline image
    Kaplan Fox Class Action Reminder: Beta Bionics, Inc. (NASDAQ: BBNX) Lead Plaintiff Deadline is November 3, 2026
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Beta Bionics, Inc. (BBNX)
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    News headline image
    Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit Against Beta Bionics, Inc. (NASDAQ: BBNX) is November 3, 2026
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    Kaplan Fox Alerts Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to a Pending Securities Class Action – Deadline is November 3, 2026
    From Kaplan Fox & Kilsheimer, LLP
    Via GlobeNewswire
    News headline image
    Kaplan Fox Deadline Alert: Beta Bionics, Inc. (NASDAQ: BBNX) Investors Have Until November 3, 2026 to Seek a Lead Plaintiff Role
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines – BBNX
    From Pomerantz LLP
    Via GlobeNewswire

    Frequently Asked Questions

    Is Beta Bionics, Inc. - Common Stock publicly traded?
    Yes, Beta Bionics, Inc. - Common Stock is publicly traded.
    What exchange does Beta Bionics, Inc. - Common Stock trade on?
    Beta Bionics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Beta Bionics, Inc. - Common Stock?
    The ticker symbol for Beta Bionics, Inc. - Common Stock is BBNX on the Nasdaq Stock Market
    What is the current price of Beta Bionics, Inc. - Common Stock?
    The current price of Beta Bionics, Inc. - Common Stock is 18.87
    When was Beta Bionics, Inc. - Common Stock last traded?
    The last trade of Beta Bionics, Inc. - Common Stock was at 10/01/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.